← Leaderboards
Vinicio A De Jesus Perez
Stanford University
$12,110,754
Attributed
$12,893,805
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,893,805 · 7
By mechanism
R01$10,751,052 · 3
R25$849,742 · 1
K08$700,812 · 1
R21$433,113 · 1
R03$159,086 · 1
Top collaborators
- Mary Red-Horse7 shared
- Joseph C Wu7 shared
- Utkan Demirci2 shared
Most similar at Stanford University
Same institution · by research overlap
- Ac Matin$5,825,181
- Stephen Paul Fortmann$14,904,234
- Latha P Palaniappan$11,769,093
- Joseph C Wu$80,370,369
- Mary Red-Horse$7,200,366
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsAngiogenesisResponseLungPulmonary Arterial HypertensionAffectCellsPathogenesisPreventSignal TransductionPathway InteractionsLifeEndothelial CellsTissuesMorphogenesisPulmonary HypertensionResearch Project GrantsPlanar Cell PolarityKnockout MiceHypoxiaEndotheliumLigandsFemale Of Child Bearing AgeGenetic
Grant awards (38)
Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension$706,109
R01 · FY2025 · HL · contact PI
The Role of the CES1 in the Pathogenesis of Pulmonary Arterial Hypertension$539,264
R01 · FY2025 · HL · contact PI
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$403,893
R01 · FY2025 · HL · contact PI
Stanford Undergraduate Summer Cardiovascular Research Program$165,812
R25 · FY2025 · HL
Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension$691,933
R01 · FY2024 · HL · contact PI
The Role of the CES1 in the Pathogenesis of Pulmonary Arterial Hypertension$539,264
R01 · FY2024 · HL · contact PI
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$481,955
R01 · FY2024 · HL · contact PI
Stanford Undergraduate URM Summer Cardiovascular Research Program$166,163
R25 · FY2024 · HL
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$116,227
R01 · FY2024 · HL · contact PI
Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension$707,873
R01 · FY2023 · HL · contact PI
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$536,042
R01 · FY2023 · HL · contact PI
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$116,227
R01 · FY2023 · HL · contact PI
Stanford Undergraduate URM Summer Cardiovascular Research Program$102,479
R25 · FY2023 · HL
Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension$732,819
R01 · FY2022 · HL · contact PI
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$577,149
R01 · FY2022 · HL · contact PI
A novel microfluidic platform to study exosome biology in PAH.$196,750
R21 · FY2022 · HL
Stanford Undergraduate URM Summer Cardiovascular Research Program$102,443
R25 · FY2022 · HL
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$71,735
R01 · FY2022 · HL · contact PI
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$547,731
R01 · FY2021 · HL · contact PI
Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension$468,923
R01 · FY2021 · HL · contact PI
A novel microfluidic platform to study exosome biology in PAH.$236,363
R21 · FY2021 · HL
Stanford Undergraduate URM Summer Cardiovascular Research Program$106,797
R25 · FY2021 · HL
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$528,319
R01 · FY2020 · HL · contact PI
Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension$468,923
R01 · FY2020 · HL · contact PI
Stanford Undergraduate URM Summer Cardiovascular Research Program$102,430
R25 · FY2020 · HL
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$556,650
R01 · FY2019 · HL · contact PI
Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension$468,923
R01 · FY2019 · HL · contact PI
Stanford Undergraduate URM Summer Cardiovascular Research Program$103,618
R25 · FY2019 · HL
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$508,800
R01 · FY2018 · HL · contact PI
Endothelial-pericyte interactions in the pathogenesis of pulmonary arterial hypertension$468,923
R01 · FY2018 · HL · contact PI
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension$513,370
R01 · FY2017 · HL · contact PI
The role of the Wnt5a/ROR2 in the pathogenesis of pulmonary arterial hypertension.$79,543
R03 · FY2017 · HL · contact PI
The role of the Wnt/planar cell polarity pathway in pulmonary angiogenesis$168,048
K08 · FY2016 · HL · contact PI
The role of the Wnt5a/ROR2 in the pathogenesis of pulmonary arterial hypertension.$79,543
R03 · FY2016 · HL · contact PI
The role of the Wnt/planar cell polarity pathway in pulmonary angiogenesis$133,191
K08 · FY2015 · HL · contact PI
The role of the Wnt/planar cell polarity pathway in pulmonary angiogenesis$133,191
K08 · FY2014 · HL · contact PI
The role of the Wnt/planar cell polarity pathway in pulmonary angiogenesis$133,191
K08 · FY2013 · HL · contact PI
The role of the Wnt/planar cell polarity pathway in pulmonary angiogenesis$133,191
K08 · FY2012 · HL · contact PI